The University of Chicago Header Logo

Connection

Clarissa Parker to Sulindac

Back to Details
This is a "connection" page, showing publications Clarissa Parker has written about Sulindac.
Clarissa Parker
Connection Strength
0.131
Sulindac
  1. Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer. J Thorac Oncol. 2006 Mar; 1(3):218-25.
    View in: PubMed
    Score: 0.131
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.